Specialty Pharmacy

California man with osteogenesis imperfecta beats HCV after treatment with Harvoni.

Patients with conditions such as rheumatoid arthritis or Crohn’s disease found to benefit from at-home treatment.

Risk of cardiovascular events increases in HIV patients who defer or interrupt treatment.

Sites like Facebook and Twitter allow patients with rare diseases to share their experiences.

New technique could soon move to clinical trials in prostate cancer.

Individualized approach allows for creation of widespread models of patient-specific tumors.

DNA screening technology up to 10,000 times more sensitive than current tests for cancer and HIV.

All diabetic neuropathies increase risk of all-cause death and adversely affect quality of life.

Are the unmeasured, potential benefits of indication-specific pricing worth the complication and risk?

A new pill makes all-oral therapy possible for patients with multiple myeloma.

HCV patients with cirrhosis and severe sepsis face elevated risk of organ failure.

Administering type 2 diabetes drugs to patients with maturity-onset diabetes of the young can cause harm.

Human epidermal growth factor receptor linked to success of chemotherapy.

Viral load predicts immune cell response in patients with HIV.

Bright white light therapy shows treats depressive symptoms in cancer patients.

Conditions such as rheumatoid arthritis and Crohn’s disease targeted by new antibody-based drug.

Sulforaphane, which occurs naturally in several cruciferous vegetables, can change the activity of endogenous enzymes.

Recurrence Score test may help some women with breast cancer be spared of chemotherapy without experiencing disease progression.

Vitamin D supplementation modifies the body's response to HIV infection

Chronic CIPN is a common side effect of chemotherapy that appears a month after treatment for cancer.

Recent advances and updates in oncology and cancer drug development.

Clotting factor deficiency causing hemophilia A may be reversed using pluripotent stem cells.

Policy decisions will affect how much biosimilars improve patient access to advanced treatments.

Study shows what couples with at least 1 HIV-positive partner want to get most out of HIV counseling, which can promote health services and treatment.

Most read articles of the week on Specialty Pharmacy Times.

Reseach may lead to new therapeutic approaches that correct disease-causing RNA behaviors.

Plitidepsin (Aplidin) in combination with dexamethasone shows 35% reduction in the risk of progression or death over comparator drug in multiple myeloma.

Trioxacarcins disrupt cancer cell replication by binding and chemically-modifying genetic material.